1 Kühlein T, Laux G, Gutscher A, Szecsenyi J. (2008). Kontinuierliche Morbiditätsregistrierung in der Hausarztpraxis – Vom Beratungsan-lass zum Beratungsergebnis. München: Urban & Vogel GmbH.
2 Riemann D, Baum E, Cohrs S, Crönlein T, Hajak G, Hertenstein E, Spiegelhalder K. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie. 2017;21:2–44.
doi: 10.1007/s11818-016-0097-x 3 Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Medicine Reviews. 2002;6:97–111.
doi: 10.1053/smrv.2002.0186 4 Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Medicine Reviews. 2015;30:11–24.
doi: 10.1016/j.smrv.2015.10.002
5 Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders. 2011;135:10–19.
doi:10.1016/j.jad.2011.01.011 6 Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression. Journal of Affective Disorders. 2003;76:255–9. doi: 10.1016/S0165-0327(02)00072-1
7 Weissmann MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. General Hospital Psychiatry. 1997;19:245–50. doi: 10.1016/S0163-8343(97)00056-X
8 Ritter P, Höfler M, Wittchen H, Lieb R, Bauer M, Pfennig A, Beesdo-Baum K. Disturbed sleep as risk factor for the subsequent onset of bipolar disorder datafroma10-yearprospective-longitudinal study among adolescents and young adults. Journal of psychiatric research. 2015;68:76–82.
doi: 10.1016/j.jpsychires.2015.06.005 9 Bernert RA, Turvey CL, Conwell Y, Joiner TE. Association of poor subjective sleep quality with risk for death by suicide during a 10-year-period – a longitudinal, population-based study of late life. JAMA Psychiatry 71. 2014;1129–37.
doi: 10.1001/jamapsychiatry.2014.112610 Bjørngaard JH, Bjerkeset O, Romundstad P, Gunnell D. Sleeping problems and suicide in 75,000 Norwegian adults: a 20-year follow-up of the HUNT I study. Sleep. 2011;34:1155–9.
doi: 10.5665/SLEEP.122811 Malik S, Kanwar A, Sim LA, Prokop LJ, Wang Z, Benkhadra K. The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Systematic Reviews. 2014;3:1–9. doi: 10.1186/2046-4053-3-18
12 Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. The Journal of Clinical Psy-chiatry. 2012;73:1160–7. doi:
10.4088/JCP.11r07586
13 Gujar N, McDonald S, Nishida M, Walker M. A role for REM sleep in recalibrating the sensitivity of the human brain to specific emoti-ons. Cerebral Cortex. 2011;21:115–23.
doi: 10.1093/cercor/bhq06414 Rosales-Lagarde A, Armony J, DelRío-Portilla Y, Trejo-Martínez D. Enhanced emotional reactivity after selective REM sleep deprivation in humans: an fMRI study. Frontiers in Behavioral Neuroscience, 6, 25.
doi: 10.3389/fnbeh.2012.00025
15 Baglioni C, Spiegelhalder K, Lombardo C, Riemann D. Sleep and emotions: a focus on insomnia. Sleep Medicine Reviews. 2010;14:227–38.
doi:10.1016/j.smrv.2009.10.007
16 Pace-Schott E, Germain A, Milad M. Effects of sleep on memory for conditioned fear and fear extinction. Psychological Bulletin. 2015;141:835–57.
doi: 10.1037/bul0000014
17 Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and deperssion. Sleep. 2007;30:873–80.
doi: 10.1093/sleep/30.7.873
18 WHO. (1992). Kapitel V – F 51.0 Insomnien. In ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf.
19 American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (DSM-5) (5th ed.). Arlington: American Psychiatric Publishing.
20 Fragebogen zur Tagesschläfrigkeit. (k.A.). Abgerufen am 18. Oktober 2018, von dgsm:
https://www.dgsm.de/downloads/fachinformationen/frageboegen/ess.pdf
21 Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evalua-te treatment response. Sleep. 2011;34:601–8.
doi: 10.1093/sleep/34.5.60122 Regensburger Insomnieskala (2003). Abgerufen am 18. Oktober 2018, von dgsm:
https://www.dgsm.de/fachinformationen_frageboegen_ris.php?language=german
23 Yang CM, Spielman AJ, Huang YS. Insomnia. Current Treatment Options in Neurology. 2005;7:373. doi: 10.1007/s11940-005-0030-2
24 Ebben MR, Spielman AJ. Non-pharmacological treatments for insomnia. Journal of Behavioral Medicine. 2009;32:244.
doi: 10.1007/s10865-008-9198-8
25 Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal. 2000;162:225–33.
26 Nowell PD., Mazumdar S, Buysse D, Dew M. Benzodiazepines and zolpidem for chronic insomnia – a meta-analysis of treatment effi-cacy. JAMA. 1997;278:2170–7.
doi: 10.1001/jama.1997.03550240060035
27 Winkler A, Auer C, Doering B, Rief W. Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized control-led trials. CNS Drugs. 2014;28:799–816. doi: 10.1007/s40263-014-0198-7
28 Kraus L, Pabst A. Epidemiologischer Suchtsurvey. Repräsentativerhebung zum Gebrauch und Missbrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland. Sucht. 2010;56:309–84.
29 Hallfors DD, Saxe L. The dependence potential of short half-life benzodiazepines. American Journal of Public Health. 1993;83:1300–4.
doi: 10.2105/AJPH.83.9.1300
31 Soldatos CR, Dikeos D, Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. International Clinical Psychopharmacology. 1999;14:287–303. doi: 10.1097/00004850-199914050-00004
31 Sun Y, Lin C, Lu C, Hsu C, Kao C. Association between zolpidem and suicide: a nationwide population-based case-control study. Mayo Clinic Proceedings. 2016;91:308–15.
doi: 10.1016/j.mayocp.2015.10.022
32 Joya FL, Kripke D, Loving R, Dawson A, Kline L. Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpi-dem. Journal of Clinical Sleep Medicine. 2009;5:377–83.
33 Dassanayake T, Micie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants, and opoids on driving. A systematic review and meta-analysis of epidemiological and experimental evidence. Drug Safety Journal. 2011;34:125–56.
doi: 10.2165/11539050-000000000-00000
34 Rapoport MJ, Lanctot K, Streiner D, Bedard M, Vingilis E, Murray B, Herrmann N. Benzodiazepine use and driving: a meta-analysis. Journal of clinical psychiatry. 2009;70:663–73.
doi: 10.4088/JCP.08m04325
35 Verster JC, Veldhuizen D, Patat A, Olivier B, Volkerts E. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Current drug safety. 2006;1:63–71.
36 Lorenz N, Heim E, Roetger A, Birrer E, Maercker A. Randomized Controlled Trial to Test the Efficacy of an Unguided Online Interventi-on with Automated Feedback for the Treatment of Insomnia. Behavioural and Cognitive Psychotherapy. 2018;1–16.
doi: 10.1017/S1352465818000486
37 Burkard M, Birrer E, Schrieken B, Michael T. (2018). Efficacy of therapist-guided internet-delivered Cognitive Behavioral Therapy for Insomnia: A randomised controlled trial. Unpublished manuscript.
38 Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – a syste-matic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews. 2016;30:1–10.
doi: 10.1016/j.smrv.2015.10.004